Avalo Therapeutics Stock Performance
as on November 17, 2026 at 7:59 am IST
Day's Low
Day's High
$7.26$7.83
1.63%
Downside
6.10%
Upside

52 Week's Low
52 Week's High
$6.53$24.27
11.52%
Downside
228.86%
Upside

Avalo Therapeutics share price movements today
- Previous Close
- $7.76
- Open
- $7.76
- Volume
- 953.8K
- Market Cap
- $448.7M
- Day's Low - High
- $7.26 - $7.83
- 52 Week Low - High
- $6.53 - $24.27
Avalo Therapeutics Historical Returns
- 1 Month Return
- -31.14 %
- 3 Month Return
- -60.39 %
- 1 Year Return
- -48.64 %
- 3 Year Return
- -64.86 %
- 5 Year Return
- -99.88 %
Avalo Therapeutics Stock Fundamentals & Key Indicators
Check Avalo Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$448.7M
EPS (TTM)
-2.89
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.69
Industry PE ratio
-5.20
PEG Ratio
0.01
EBITDA
-88.4M
Revenue (TTM)
59.0K
Profit Margin
71.19%
Return On Equity TTM
-34.21%
Avalo Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Avalo Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $448.7M | -99.88% | -2.69 | 71.19% | 0.00% | |
| Neutral | $100.6B | 0.07% | -35.18 | 28.00% | 0.00% | |
| StrongBuy | $47.6B | NA | 67.06 | 88.39% | 0.00% | |
| StrongBuy | $136.6B | 185.99% | 34.39 | 85.57% | 0.00% | |
| Buy | $98.8B | 48.65% | 20.35 | 85.77% | 0.39% |
Stock Returns calculator for Avalo Therapeutics Stock including INR - Dollar returns
The Avalo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Avalo Therapeutics investment value today
Current value as on today
₹51,755
Returns
Returns from Avalo Therapeutics Stock
Dollar Impact
₹2,913 (+2.91%)
Analyst Recommendation on Avalo Therapeutics Stock
Based on 5 analysts
60.00%
Buy
40.00%
Hold
0.00%
Sell
Based on 5 analysts, 60% of analysts recommend a 'BUY' rating for Avalo Therapeutics. Average target price of $34.8
Avalo Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Avalo Therapeutics.
What analysts predicted
78.79%UPSIDE
Target Price
$34.8
Current Price
$7.38
Analyzed by
5 Analysts
High
$60
Target
$34.80
Low
$10
Avalo Therapeutics target price $34.8, a slight upside of 78.79% compared to current price of $7.38. According to 5 analysts rating.
Indian Investors' Interest in Avalo Therapeutics Stock
Search interest for Avalo Therapeutics Stock has increased by 150% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:150% versus previous 30 day period
Avalo Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Avalo Therapeutics Annual Profit & Loss
All numbers in Millions USD
Avalo Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Avalo Therapeutics Annual Cash Flow
All numbers in Millions USD
Avalo Therapeutics News & Key Events

Today's Timeline - 23 October
Fri, 05:06 PM
-Guggenheim downgraded Avalo Therapeutics to Neutral, citing weak Phase 3 INTREPID study results for lutikizumab.
Insights on Avalo Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 7 days, AVTX stock has moved up by 6.7%
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, -36.35M → -18.94M (in $), with an average increase of 91.9% per quarter
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 850.4%
NO EFFECTAgainst Peers

In the last 3 years, Moderna, Inc. Common Stock has given 191.8% return, outperforming this stock by 256.7%
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 4 quarters, 571.0K → 59.0K (in $), with an average decrease of 49.5% per quarter
About Avalo Therapeutics
| Organisation | Avalo Therapeutics |
| Headquarters | 1500 Liberty Ridge Drive, Wayne, PA, 19087, US |
| Industry | Biotechnology |
| CEO | Garry A. Neil |
Key Management of Avalo Therapeutics
Name | Title |
|---|---|
Dr. Barbara S. Slusher Ph.D. | Founder and Member of Scientific Advisory Board |
Ms. Ashley Ivanowicz | Senior Vice President of Human Resources |
Dr. Garry A. Neil M.D. | President, CEO & Director |
Mr. Taylor Boyd | Chief Business Officer |
Dr. Solomon H. Snyder M.D. | Founder and Chairman of Scientific Advisory Board |
Mr. Christopher Ryan Sullivan CPA | CFO & Head of Investor relations |
Mr. Paul C. Varki J.D., M.P.H | Chief Legal Officer |
Dr. Dino C. Miano Ph.D. | Senior Vice President of CMC & Technical Operations |
Ms. Jennifer Riley | Chief Strategy Officer |
Dr. Mittie Doyle FACR, M.D. | Chief Medical Officer |
FAQs
What is Avalo Therapeutics share price today?
Avalo Therapeutics share price today is $7.38 as on at the close of the market. Avalo Therapeutics share today touched a day high of $7.83 and a low of $7.26.
What is the 52 week high and 52 week low for Avalo Therapeutics share?
Avalo Therapeutics share touched a 52 week high of $24.27 on and a 52 week low of $6.53 on . Avalo Therapeutics stock price today i.e. is closed at $7.38,which is 69.59% down from its 52 week high and 13.02% up from its 52 week low.
What is Avalo Therapeutics's market capitalisation today?
Avalo Therapeutics market capitalisation is $0.00T as on .
How to invest in Avalo Therapeutics Stock (AVTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Avalo Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Avalo Therapeutics Stock (AVTX) from India?
Indian investors can start investing in Avalo Therapeutics (AVTX) shares with as little as ₹93.92250061035156 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.23 in Avalo Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Avalo Therapeutics share’s latest price of $7.38 as on November 17, 2026 at 2:29 am IST, you will get 1.3550 shares of Avalo Therapeutics. Learn more about
fractional shares .
What are the returns that Avalo Therapeutics has given to Indian investors in the last 5 years?
Avalo Therapeutics stock has given -99.88% share price returns and 26.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?